Non-alcoholic steatohepatitis (NASH) is characterized by liver steatosis and inflammation. Currently, the underlying mechanisms leading to hepatic inflammation are not fully understood and consequently, therapeutic options are poor. Non-alcoholic steatohepatitis (NASH) and atherosclerosis share the same etiology whereby macrophages play a key role in disease progression. Macrophage function can be modulated via activation of receptor-ligand binding of Notch signaling. Relevantly, global inhibition of Notch ligand Delta-Like Ligand-4 (DLL4) attenuates atherosclerosis by altering the macrophage-mediated inflammatory response. However, the specific contribution of macrophage DLL4 to hepatic inflammation is currently unknown. We hypothesized that myeloid DLL4 deficiency in low-density lipoprotein receptor knock-out (Ldlr In line, in vitro, there was no difference in the expression of inflammatory genes between DLL4-deficient and wildtype bone marrowderived macrophages. These results suggest that myeloid DLL4 deficiency does not contribute to hepatic inflammation in vivo. Since, macrophage-DLL4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Nevertheless, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis.
Introduction
NASH is characterized by an increase in fat accumulation (steatosis) and inflammation in the liver. The prevalence of steatosis is estimated to be ranging from 84% to 96% whereas in this population the prevalence of NASH is ranging from 25% to 55% [1] . Although steatosis is a rather benign and reversible condition, the presence of inflammation is the key feature of NASH, which can lead to further disease progression and eventually lead to liver cirrhosis [2, 3] . The exact mechanisms leading to hepatic inflammation are unknown and more insights are needed in order to discover novel therapeutic strategies.
Current research recognizes the critical role of Notch signaling in the context of immune cells [4] . Notch signaling occurs upon interaction of Notch receptors (e.g. Notch-1, -2, -3 or -4) on signal receiving cells and their membrane ligands (e.g. Jagged-1 (J1), Jagged-2 (J2), Delta-Like Ligand-1 (DLL1), Delta-Like Ligand-3 (DLL3) or Delta-Like Ligand-4 (DLL4)) on signal sending cells. Notch signaling has been implicated in the innate and adaptive immunity, which play an important role in various metabolic disorders [4] [5] [6] [7] . An increasing amount of evidence point towards the existence of a shared inflammatory etiology between NASH and atherosclerosis with a central role for macrophages [8] . Fukuda et al. showed that global inhibition of DLL4 ameliorates atherosclerosis by altering macrophage-induced inflammatory responses, suggesting the importance of DLL4 on macrophage-mediated vascular inflammation [9, 10] . In NASH, Kupffer cells (KCs), the resident macrophages of the liver, play a central role in the initiation of hepatic inflammation and disease progression [8, 11, 12] . Relevantly, it was shown that Notch downstream targets are positively correlated with steatosis and inflammation in a cohort of non-alcoholic fatty liver disease (NAFLD) patients [13] . Furthermore, hepatic Notch activation lead to lipogenic gene expression and steatosis in chow fed mice whereas (DLL4)-Notch signaling promotes a fatty liver [9, 10, 14] .
So far, the exact contribution DLL4-Notch in macrophages has not been investigated in the context of NASH. We hypothesized that myeloid DLL4 deficiency in low-density lipoprotein receptor knock-out (Ldlr -/-) mice reduces hepatic inflammation. To test this hypothesis, bone marrow of wild-type (Wt) or myeloid DLL4-deficient (DLL4 del ) mice was transplanted (-tp) into lethally irradiated Ldlr -/-recipient mice and were fed chow or HFC for 11 weeks after a recovery period of 9 weeks. In contrast to our expectations, myeloid deletion of DLL4 did not reduce hepatic inflammation. These results suggest that myeloid DLL4 deficiency does not contribute to hepatic inflammation in vivo. Since, macrophage-DLL4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Nevertheless, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis.
Materials and Methods
Mice, bone marrow transplantation and diet
All animals were housed under standard conditions and had access to food and water ad libitum. The animal experiments were approved by the committee for Animal Welfare of Maastricht University and were performed according to Dutch regulations. The DLL4 flox/flox mice were kindly donated by Prof. Freddy Radtke [15] , and crossbred with LysMCre mice [16] 
Kupffer cell isolation
Whole liver (n = 4) of each experimental group were digested individually in digestion buffer (33.9 μg/ml Liberase TM, 0.002% DNaseI) for 20 min at 37˚C. The digested liver solution was further disrupted by pushing it through a 100 μm cell strainer using wash buffer (PBS, 1% FCS and 2.5 mM EDTA). Cells were then centrifuged at 1500 rpm for 10 min at 4˚C. Pellet was resuspended in wash buffer, removal of hepatocytes was accomplished by one low-spin centrifugation step at 300 rpm for 3 min. Supernatant, which was lysed from red blood cells, was collected and centrifuged. Next, Kupffer cells were isolated from the supernatant by using magnetic beads coated with a macrophage-specific monoclonal antibody (F4/80-APC, 1 μl/ 
RNA isolation and quantitative polymerase chain reaction
Total RNA was isolated from frozen mouse liver and Kupffer cells as described previously [17, 18] . 
Statistical analysis
Significant differences between the experimental groups were analyzed with the two-way ANOVA followed by a Tukey post-hoc test using the IBM 1 SPSS Statistics program (Version 22.0.0.). In vitro results were analyzed for significant differences with the two-tailed unpaired t-test using GraphPad Prism (Version 5.03). Outliers were determined via the Grubbs' Test. Data were expressed as the mean ±SEM and considered significant at p < 0.05. Ã , ÃÃ and ÃÃÃ indicate p < 0.05, 0.01 and 0.001 resp.
Results
Myeloid DLL4 deficiency has no effect on plasma and liver lipid levels
To investigate the effect of myeloid DLL4 deficiency on the health status of Wt-tp and DLL4 del -tp mice, relative weight gain and liver/body weight ratio were determined. As expected, upon HFC, both the relative weight gain and liver/body weight ratio were increased compared to chow. No differences were observed between Wt-tp and DLL4 del -tp mice (Fig 1A  and 1B) . To determine the extent of liver damage, the liver enzyme alanine aminotransferase (ALT) was measured. Upon HFC feeding, ALT levels were increased in Wt-tp and DLL4 del -tp mice compared to chow, but levels remained similar between both groups ( Fig 1C) . Next, we investigated the effect of myeloid DLL4 on plasma and liver lipid levels. Upon HFC feeding, cholesterol and triglyceride levels were increased in Wt-tp and DLL4 del -tp mice. However, no significant differences were observed between both groups in both plasma and liver (Fig 2A-2D) . To further determine the effects of myeloid DLL4 deficiency on cholesterol metabolism, gene expression of ATP-binding cassette subfamily A member 1 (Abca1), ATP-binding cassette subfamily G member 1 (Abcg1), Liver X receptor alpha (Lxrα) and Cluster of Differentiation 36 (Cd36) were analyzed in the livers of Wt-tp and DLL4 del -tp mice. Gene expression of Abca1 and Cd36 were significantly upregulated in the livers of Wt-tp and DLL4 del -tp mice on an HFC diet compared to chow-fed mice. Similar hepatic mRNA levels were detected between Wt-tp and DLL4 del -tp mice when fed chow or HFC (Fig 2E) . Altogether, these data suggest that myeloid DLL4 signaling has no effect on lipid metabolism.
Hepatic inflammation is not changed in myeloid DLL4-deficient mice
To investigate that DLL4 is knocked down specifically in myeloid cells, we first determined DLL4 expression in whole livers of Wt-and DLL4 del -tp mice. We found that Dll4 expression both on mRNA and protein level in whole livers was similar between Wt-tp and DLL4 del -tp mice (Fig 3A and 3C, respectively) . Next, protein expression of DLL4 was assessed in Wt and DLL4 del BMDM. In line with our gene expression data regarding DLL4 in Kupffer cells (Fig   3D) , DLL4 protein expression was reduced in DLL4 del BMDM compared to Wt BMDM ( Fig   3B) . Altogether, these data indicate that DLL4 deficiency is selective for myeloid cells. To determine the effect on myeloid DLL4 deficiency on Notch signaling, the expression of Notch target genes was investigated in the livers of Wt-tp and DLL4 del -tp mice. Gene expression analysis of the downstream targets of DLL4, Hairy/enhance of split-1 (Hes1) and Hairy/enhancer-of-split related with YRPW motif protein 1 (Hey1), was analyzed. Upon HFC feeding, Hey1 and Hes1 expression was increased in Wt-tp and DLL4 del -tp mice, indicative for increased Notch signaling activation. However, no changes in Hey1 and Hes1 were observed between both groups ( Fig  3F and 3G) . Additionally, Hes1 gene expression in KCs of Wt-tp and DLL4 del -tp mice on chow and HFC diet was determined. No differences were observed in Hes1 gene expression between KCs of Wt and DLL4 del -tp mice (Fig 3E) . Next, gene expression of Notch-receptors and ligands were measured in the livers of Wt-tp and DLL4 del -tp mice. Upon HFC, gene expression of Notch-1, Notch-3, and Jagged-1 was increased compared to chow-fed mice in both Wt-tp and DLL4 del -tp mice, whereas Dll1 gene expression was reduced. However, no differences were observed between Wt-tp and DLL4 del -tp mice in either the chow or HFC group (S1 Fig). Similar findings were observed in BMDM of Wt and DLL4 del mice; upon LPS stimulation, the expression of Notch-1, Notch-2 and Dll1 was increased in both Wt and DLL4 del BMDM, whereas Jagged-2 gene expression was reduced compared to non-stimulated conditions. No Altogether, these findings suggest that hematopoietic deletion of DLL4 is not associated with changes in the expression of other Notch receptors or ligands. Next, to investigate whether myeloid DLL4 deficiency lowers hepatic inflammation, immunohistological stainings and gene expression analysis were performed on liver tissue of Wt-tp and DLL4 del -tp mice. First, we performed an H&E staining on liver sections of Wt-tp and DLL4 del -tp mice. These sections were scored for steatosis and liver cell injury (e.g. necrosis, inflammation, bile duct formation) by an experienced mouse pathologist in a blinded manner. Histological analysis revealed that, upon an HFC diet, steatosis and liver cell injury was pronounced in both Wt-tp and DLL4 del -tp mice. These findings were also supported by ALAT plasma levels, which is a marker for liver injury (Fig 1C) . In line with our previously obtained results, no differences were observed between the two genotypes ( S3 Fig). These data further support the conclusion that myeloid DLL4 deficiency does not affect liver steatosis and hepatic inflammation. Additionally, liver sections were stained for infiltrated macrophages (MAC-1 staining) and neutrophils (NIMP staining). Upon HFC feeding, infiltrated macrophages were increased in Wt-tp and DLL4 del -tp mice compared to chow-fed mice. Similar effects were observed for neutrophils. However, no differences were observed between the two genotypes in the chow-and HFC-fed group for infiltrated macrophages and neutrophils (Fig 4A-4C) . Moreover, gene expression levels of Tnfα, Integrin Alpha M (Itgam) and Intercellular Adhesion Molecule 1 (Icam) were similar between Wt-tp and DLL4 del -tp mice (Fig 4D) . To determine foam cell formation a CD68 staining was performed on livers of Wt-tp and DLL4 del -tp mice. There were no differences in foam cell formation between Wt-tp and DLL4 del -tp HFC fed mice (data not shown). Overall, these results suggest that myeloid DLL4 deficiency does not lower hepatic inflammation.
DLL4 deficiency does not affect inflammatory gene expression in bone marrow-derived macrophages
As we did not observe differences on hepatic inflammation in vivo, we next investigated whether bone marrow-derived macrophages (BMDM) of myeloid DLL4-deficient mice are less susceptible for inflammation. Bone marrow from DLL4 f/f LysMCre Wt (Wt) and DLL4 f/f LysMCre +/0 (DLL4 del ) was isolated and differentiated to BMDM followed by an LPS stimulus. As expected, DLL4 del BMDM showed a significant reduction of DLL4 expression when compared to Wt macrophages (Fig 5A) . However, no significant differences in TNFα cytokine production, Tnfα and Itgam expression were detected when compared to Wt BMDM upon LPS stimulation (Fig 5B-5D ). While the differences between the groups for Dll4 and Itgam gene expression remain similar in the condition without LPS, TNFα cytokine production was not detectable. Tnfα gene expression levels were increased significantly in Wt and DLL4 del BMDM due to the LPS stimulus. These data show that DLL4 del BMDM can contribute to inflammation to the same extent as compared to Wt BMDM. To investigate the relative contribution of DLL4 to LPS-induced inflammation, DLL4 was immobilized in culture plates, where it acts as an inflammatory stimulus on Wt BMDM in the absence of LPS. Upon DLL4 stimulation, gene expression of Tnfα was significantly increased. A similar trend was observed in TNFα cytokine production. However, in the absence of LPS, the levels of TNFα cytokine production are extremely low (±1.5-3.0 pg/ml) (Fig 5E) . These data suggest a minor role for myeloid DLL4 in triggering inflammation.
Discussion
Notch signaling is involved in various metabolic diseases [7, 9, 13, 22] and has been described as an essential modulator for inflammation and macrophage function [7, [23] [24] [25] [26] [27] . While many Notch ligands have been investigated thoroughly, in the current study, we investigated for the first time the contribution of myeloid DLL4 in the context of hepatic inflammation.
Macrophage activation is essential for atherosclerotic plaque development [28] [29] [30] [31] and recent studies have implicated Notch signaling in this process [9, 23, 32] . These studies showed that DLL4 ligand-expressing macrophages are found in human atherosclerotic lesions and that pro-inflammatory stimuli can increase DLL4 expression in macrophages [23] . Furthermore, it has been shown in vivo that plaque progression was reduced in apolipoprotein E-deficient mice after treatment with a γ-secretase, in order to inhibit Notch signaling [32] . Taken into account the prominent role of Notch signaling in atherosclerosis, and since NASH and atherosclerosis share similar disease mechanisms [8] , the results obtained in the current study were unexpected. In contrast to our results, global inhibition of DLL4 using specific antibodies resulted in a reduction in plaque development and decreased fat accumulation in Ldlr -/-mice.
Next to that, they showed that F4/80 gene expression in the liver was reduced in these mice [9, 10] , while our result showed no differences in hepatic inflammation. In vitro data from our group and others demonstrated the pro-inflammatory role of DLL4 on macrophages. However, data regarding the role of DLL4 on cells other than macrophages is lacking. In our experimental design, the DLL4 deletion is restricted to myeloid cells. In contrast, Fukuda et al. used a global inhibition of DLL4 (via anti-DLL4 antibodies) [9] . It is therefore possible that in vivo, the contribution of DLL4 on myeloid cells is minor and cells other than macrophages contribute to the inflammatory response, as observed by Hoebe et al. [33] . For example, when stromal cells, that express DLL4, were co-cultured with macrophages, the inflammatory response was increased, compared to stromal cells without DLL4 co-incubated with macrophages [23] . These data demonstrate the contribution of other DLL4-expressing cells to inflammation. In line, there is evidence that Notch receptors can be activated through other Notch ligands [34] [35] [36] [37] . Furthermore, Notch-1, -2 and -3 are highly expressed on monocytes and macrophages and in vitro studies have shown that these cells can undergo cytokine specific apoptosis by interaction of DLL1 which could influence the macrophage inflammatory response [23, 25, 38] . Next to that, it can be speculated that DLL4-expressing hepatocytes may also affect myeloid DLL4-Notch signaling, as myeloid DLL4 signaling is mediated through all four Notch receptors [23, 39, 40] . Additionally, DLL4 induces Notch-1, -2, -3 cleavages [41] . As such it is likely that, macrophages in DLL4 del -tp mice could still be activated via hepatic DLL4. Interestingly, Koga et al, showed that Ldlr -/-hyperlipidemic mice showed high levels of soluble DLL4
in the plasma compared to Wt mice [42] . Fung et al, already showed that soluble DLL4 is able to activate Notch signaling in macrophages [23] . Based on these observations it can be suggested that in our model hepatocytes could still be functioning as suitable donor for DLL4 activation as they still express DLL4.
In conclusion, our data suggest that the inhibition of one single Notch-ligand in the myeloid linage is not sufficient to overcome hepatic inflammation. Nevertheless, since the macrophage-Dll4 expression in our model was not completely suppressed, it can't be totally excluded that complete DLL4 deletion in macrophages might lead to different results. Furthermore, there is a possibility that Kupffer cell isolation using magnetic beads may contain other cells such as endothelial cells, which could explain for these findings. Finally, the contribution of non-myeloid Kupffer cells to notch signaling with regard to the pathogenesis of steatohepatitis is unknown and as such it is possible that, DLL4 on Kupffer cells promote the pathogenesis of steatohepatitis. Therefore, further research should emphasize on the effects of complete DLL4 deletion in myeloid cells and the contribution of non-myeloid cells to DLL4-Notch signaling. 
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